FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804643570> ?p ?o ?g. }

• W2804643570 endingPage "1519" @default.
• W2804643570 startingPage "1513" @default.
• W2804643570 abstract "OBJECTIVE Retrospective clinical data and case studies support a therapeutic effect of ketamine in suppression of spreading depolarization (SD) following brain injury. Preclinical data strongly support efficacy in terms of frequency of SD as well as recovery from electrocorticography (ECoG) depression. The authors present the results of the first prospective controlled clinical trial testing the role of ketamine used for clinical sedation on occurrence of SD. METHODS Ten patients with severe traumatic brain injury (TBI) or aneurysmal subarachnoid hemorrhage (SAH) were recruited for this pilot trial. A standard ECoG strip was placed at the time of craniotomy, and the patients were then placed on an alternating every-6-hour schedule of ketamine or other sedation agent. The order of treatment was randomized. The ketamine dose was adjusted to clinical effect or maintained at a subanesthetic basal dose (0.1 mg/kg/hr) if no sedation was required. SD was scored using standard criteria, blinded to ketamine dosing. Occurrence of SD was compared with the hourly dose of ketamine to determine the effect of ketamine on SD occurrence. RESULTS Successful ECoG recordings were obtained in all 10 patients: 8 with SAH and 2 with TBI. There were a total of 1642 hours of observations with adequate ECoG: 833 hours off ketamine and 809 hours on ketamine. Analysis revealed a strong dose-dependent effect such that hours off ketamine or on doses of less than 1.15 mg/kg/hr were associated with an increased risk of SD compared with hours on doses of 1.15 mg/kg/hr or more (OR 13.838, 95% CI 1.99–1000). This odds ratio decreased with lower doses of 1.0 mg/kg/hr (OR 4.924, 95% CI 1.337–43.516), 0.85 mg/kg/hr (OR 3.323, 95% CI 1.139–16.074), and 0.70 mg/kg/hr (OR 2.725, 95% CI 1.068–9.898) to a threshold of no effect at 0.55 mg/kg/hr (OR 1.043, 95% CI 0.565–2.135). When all ketamine data were pooled (i.e., on ketamine at any dose vs off ketamine), a nonsignificant overall trend toward less SD during hours on ketamine (χ 2 = 3.86, p = 0.42) was observed. CONCLUSIONS Ketamine effectively inhibits SD over a wide range of doses commonly used for sedation, even in nonintubated patients. These data also provide the first prospective evidence that the occurrence of SD can be influenced by clinical intervention and does not simply represent an unavoidable epiphenomenon after injury. These data provide the basis for future studies assessing clinical improvement with SD-directed therapy. Clinical trial registration no.: NCT02501941 (clinicaltrials.gov)" @default.
• W2804643570 created "2018-06-01" @default.
• W2804643570 creator A5038958115 @default.
• W2804643570 creator A5047734330 @default.
• W2804643570 creator A5070492897 @default.
• W2804643570 creator A5080405056 @default.
• W2804643570 creator A5080852193 @default.
• W2804643570 date "2019-05-01" @default.
• W2804643570 modified "2023-10-14" @default.
• W2804643570 title "Spreading depolarization in acute brain injury inhibited by ketamine: a prospective, randomized, multiple crossover trial" @default.
• W2804643570 cites W1482910955 @default.
• W2804643570 cites W1508189110 @default.
• W2804643570 cites W1965983192 @default.
• W2804643570 cites W1971854717 @default.
• W2804643570 cites W1975980016 @default.
• W2804643570 cites W1980291572 @default.
• W2804643570 cites W1980752835 @default.
• W2804643570 cites W1989124609 @default.
• W2804643570 cites W1991333985 @default.
• W2804643570 cites W2014682794 @default.
• W2804643570 cites W2018656583 @default.
• W2804643570 cites W2023072747 @default.
• W2804643570 cites W2053310304 @default.
• W2804643570 cites W2060215608 @default.
• W2804643570 cites W2065068139 @default.
• W2804643570 cites W2065605263 @default.
• W2804643570 cites W2075166773 @default.
• W2804643570 cites W2075473660 @default.
• W2804643570 cites W2075963191 @default.
• W2804643570 cites W2079170612 @default.
• W2804643570 cites W2082309331 @default.
• W2804643570 cites W2083091419 @default.
• W2804643570 cites W2101308371 @default.
• W2804643570 cites W2129867971 @default.
• W2804643570 cites W2144759791 @default.
• W2804643570 cites W2151777259 @default.
• W2804643570 cites W2169632325 @default.
• W2804643570 cites W2169684975 @default.
• W2804643570 cites W2171985497 @default.
• W2804643570 cites W2217637761 @default.
• W2804643570 cites W2330813625 @default.
• W2804643570 cites W2404280519 @default.
• W2804643570 cites W2413014582 @default.
• W2804643570 cites W2413204676 @default.
• W2804643570 cites W2430451014 @default.
• W2804643570 cites W2471954838 @default.
• W2804643570 cites W2571918371 @default.
• W2804643570 cites W2801081358 @default.
• W2804643570 cites W4237638794 @default.
• W2804643570 doi "https://doi.org/10.3171/2017.12.jns171665" @default.
• W2804643570 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6279620" @default.
• W2804643570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29799344" @default.
• W2804643570 hasPublicationYear "2019" @default.
• W2804643570 type Work @default.
• W2804643570 sameAs 2804643570 @default.
• W2804643570 citedByCount "66" @default.
• W2804643570 countsByYear W28046435702019 @default.
• W2804643570 countsByYear W28046435702020 @default.
• W2804643570 countsByYear W28046435702021 @default.
• W2804643570 countsByYear W28046435702022 @default.
• W2804643570 countsByYear W28046435702023 @default.
• W2804643570 crossrefType "journal-article" @default.
• W2804643570 hasAuthorship W2804643570A5038958115 @default.
• W2804643570 hasAuthorship W2804643570A5047734330 @default.
• W2804643570 hasAuthorship W2804643570A5070492897 @default.
• W2804643570 hasAuthorship W2804643570A5080405056 @default.
• W2804643570 hasAuthorship W2804643570A5080852193 @default.
• W2804643570 hasBestOaLocation W28046435701 @default.
• W2804643570 hasConcept C118552586 @default.
• W2804643570 hasConcept C122356138 @default.
• W2804643570 hasConcept C126322002 @default.
• W2804643570 hasConcept C141071460 @default.
• W2804643570 hasConcept C142724271 @default.
• W2804643570 hasConcept C168563851 @default.
• W2804643570 hasConcept C204787440 @default.
• W2804643570 hasConcept C27081682 @default.
• W2804643570 hasConcept C2776814716 @default.
• W2804643570 hasConcept C2778186239 @default.
• W2804643570 hasConcept C2778541695 @default.
• W2804643570 hasConcept C2780117969 @default.
• W2804643570 hasConcept C2780795376 @default.
• W2804643570 hasConcept C2781017439 @default.
• W2804643570 hasConcept C42219234 @default.
• W2804643570 hasConcept C535046627 @default.
• W2804643570 hasConcept C71924100 @default.
• W2804643570 hasConcept C87813604 @default.
• W2804643570 hasConceptScore W2804643570C118552586 @default.
• W2804643570 hasConceptScore W2804643570C122356138 @default.
• W2804643570 hasConceptScore W2804643570C126322002 @default.
• W2804643570 hasConceptScore W2804643570C141071460 @default.
• W2804643570 hasConceptScore W2804643570C142724271 @default.
• W2804643570 hasConceptScore W2804643570C168563851 @default.
• W2804643570 hasConceptScore W2804643570C204787440 @default.
• W2804643570 hasConceptScore W2804643570C27081682 @default.
• W2804643570 hasConceptScore W2804643570C2776814716 @default.
• W2804643570 hasConceptScore W2804643570C2778186239 @default.
• W2804643570 hasConceptScore W2804643570C2778541695 @default.
• W2804643570 hasConceptScore W2804643570C2780117969 @default.

• next